Mirum Pharmaceuticals, Inc. (MIRM)
94.62
+2.24
(+2.42%)
USD |
NASDAQ |
Apr 01, 16:00
93.00
-1.62
(-1.71%)
After-Hours: 05:21
Mirum Pharmaceuticals Research and Development Expense (TTM) : 185.83M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Insmed, Inc. | 771.09M |
| Ionis Pharmaceuticals, Inc. | 914.12M |
| BridgeBio Pharma, Inc. | 451.95M |
| XOMA Royalty Corp. | 1.712M |